Biogen investigated by Dutch antitrust regulator over Stratify test
By Jean Comte ( October 28, 2026, 16:56 GMT | Insight) -- US biotechnology Biogen is being probed by the Dutch competition authority over potential abuse of dominant position related to its anti-JCV test Stratify, the regulator told MLex. The ACM said it was in contact with its Italian counterpart, which opened a similar investigation in May.US biotechnology Biogen is being investigated by the Autoriteit Consument & Markt — the Dutch antitrust regulator — over its anti-JCV test Stratify, a few months after the Italian competition authority started a similar investigation....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.